Spliff Seeds - Gold Line Neville's Haze Feminised
95% Sativa. Genotype: Afghani #1 x Original Haze xNL. Pine cone aroma and floral, sweet and sour haze flavor. Fastflowering 8-9 weeks. Medicinal value: ADHD and pain relief. Strong psycho-active high. Potential THC level high.This hybrid has Afghan, Original Haze and Northern Lights heritage. The original Haze has exotic genes; Thai, Indian, Mexican and Colombian Sativa. An 80% Sativa plant with a high THC level and a high CBD. The Neville’s haze is as pure haze as you can get and has great medicinal value. Our Neville’s Haze has been backcrossed to stabilize her and to cut down height. She will carry on flowering long after 12 weeks, which is unique. The longer you leave the more THC will break down into CBD, creating a more stoned buzz. She is a very pure haze strain (very medicinal!). Neville's is a big yielding strain and flowers very quickly for a Haze strain. She will reach fruition in about 8 to 9 weeks. So very quick indeed for a haze. One of the quickest Haze strains around. She has a typical sativa structure; stretched and wide and narrow fan leaves. She will form one giant main bud and produce small, nugs all over the plant. From top to bottom. She is not a bushy plant at all, letting light easily pass through to the lower buds and internodes. This will make for white buds all over the plant. These buds are not as compact as an Indica dominant plant, but the overall yield is very impressive. Put her directly under a 12/12 schedule or a very limited pregrow phase with continuous light (24/7) to limit height. 6 plants per square metre is max, because they need room to grow. She is a thinly, branched plant with slim, darkgreen leaves. 1 out of 5 plants can produce bananas after 7 weeks of flowering but you needn’t worry. These banana do not contain pollen! She has a pine cone smell has a sweet and sour, floral haze taste. Neville’s Haze has a strong psycho-active high. Medicinal value: Crohn’s Disease, epilepsy, multiple sclerosis, and other seizure-related illnesses. Details:
|
